← Eichor
Study identifier: NCT06205862 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)

Condition: Fecal Microbiota Transplantation · Colorectal Adenoma · Gastrointestinal Microbiome  ·  Sponsor: Shenzhen Hospital of Southern Medical University

PhasePhase 2
Planned participants466
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn about the efficacy and safety of fecal microbiota transplantation in reducing recurrence of colorectal adenomas after endoscopic resection. The main questions it aims to answer are: * the efficacy and safety of fecal microbiota transplantation in reducing the recurrence rate of colorectal adenomas after endoscopic resection. * changes in the intestinal and mucosal microbiota of patients before and after endoscopic treatment. * changes in the intestinal and mucosal microbiota of patients before and after fecal microbiota transplantation. Participants are required to complete one colonoscopy and infuse 150ml of fecal suspension into the terminal ileum under endoscopy, performing the first fecal microbiota transplantation (FMT) on day 0. Subsequently, for 2 days continuously (day 1-2), the participants will undergo microbiota transplantation in the form of oral capsules, taking 40 FMT capsules within one day (20 capsules bid). Subsequently, participants will receive a maintenance treatment with oral FMT capsules (20 capsules bid) at 3, 6, and 9 months (approximately every 75 to 90 days). Participants will undergo their first follow-up colonoscopy between 6 to 12 months(the high-risk adenoma group will receive colonoscopy at 6 months, and the low-risk adenoma group will receive colonoscopy at 12 months).

This description comes directly from the study's public registry record.

Talk to the study team

Jun Huang  ·  +8613189606428  ·  1473355495@qq.com

Always discuss trial participation with your own doctor first.

Locations (5)

Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, ChinaWithdrawn
Shenzhen Hospital of Southern Medical UniversityShenzhen, Guangdong, ChinaRecruiting
Luohu District People's HospitalShenzhen, Guangdong, ChinaNot Yet Recruiting
Shenzhen University General HospitalShenzhen, Guangdong, ChinaNot Yet Recruiting
Shunde Hospital of Southern Medical UniversityShunde, Guangdong, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06205862